-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
PMV Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2019 to Q2 2024.
- PMV Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$20.2M, a 0.24% decline year-over-year.
- PMV Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$76.9M, a 6.35% increase year-over-year.
- PMV Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$80.1M, a 4.01% decline from 2022.
- PMV Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$77M, a 32.2% decline from 2021.
- PMV Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$58.3M, a 66.8% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)